Tag Archive

The rapid proliferation of gender ideology over the past decade—especially the surge of adolescent-onset gender dysphoria—stands as one of the clearest examples of social contagion in modern Western societies. A clinical framework once reserved for a very small number of adults with persistent, childhood-onset dysphoria was transformed into a cultural mandate through the convergence of three forces: institutional capture, algorithm-driven identity formation, and activist-driven medical practice.

Between 2015 and the early 2020s, referrals for gender services exploded—driven overwhelmingly by teenage girls with no prior history of dysphoria. Peer-group clustering, sudden identity shifts following intense online exposure, and the complete inversion of historic sex ratios all point to a socially transmitted phenomenon rather than a newly discovered biological one. Yet under the “affirmation” model, minors were placed on puberty blockers, cross-sex hormones, and permanent surgeries despite limited evidence, poorly understood risks, and a professional culture that increasingly discouraged clinical skepticism.

The hardest obstacle to unwind, however, will not be the institutions that enabled this shift. Policies can change, clinics can be restructured, and professional bodies can revise guidelines—as they already have across parts of Europe. The most immovable barrier will be parents. Many acted from compassion, social pressure, or a sincere desire to be “supportive,” but they now face an excruciating truth: they approved irreversible medical interventions on psychologically vulnerable teenagers during a developmental window historically marked by transient distress, identity confusion, and social sensitivity.

Double mastectomies on minors, lifetime fertility loss, and surgeries with complication rates exceeding anything considered acceptable elsewhere in medicine are not abstract debates. They are lived consequences. For parents, acknowledging error would require confronting a moral reality few can bear: that they were active participants in harming their own child. The human mind is built to avoid that revelation at all costs.

As a result, the detransition wave—real, growing, and increasingly documented—will face its fiercest resistance not from clinics or activists, but from within families. Parents will cling to the “lifesaving care” narrative long after the institutions that encouraged it have quietly retreated. They will reinterpret events to preserve psychic stability, even if doing so deepens the suffering of the child who must now live with the consequences.

Reversing the damage will require more than policy reform or legal accountability. It will require a public reckoning with the psychological mechanisms of self-deception, moral injury, and sunk-cost loyalty that allowed an entire society to medicate and operate on distressed adolescents in the name of affirmation. That reckoning—private, painful, and unavoidable—is the hardest part still to come.

References

• The Cass Review – Independent Review of Gender Identity Services for Children and Young People (Interim Report) — NHS-commissioned review (Feb 2022) by Dr. Hilary Cass. Sex Matters

• The Cass Review: Final Report (April 2024) — Hilary Cass’s full independent review. BASW+1

• NHS England: Public Consultation Analysis & Summary – Interim Clinical Policy on Puberty-Suppressing Hormones (Jan 2024) — analysis of feedback on proposed policy changes. NHS England

• Commission on Human Medicines (UK) Report – Proposed Restriction on GnRH Agonists for Under-18s — recommendation to restrict puberty blockers. GOV.UK

• Equality & Health Inequalities Impact Assessment (EHIA), NHS England — assessment of health-inequality risks from the policy change on puberty blockers. GOV.UK+1

• Karolinska Institutet Systematic Review on Hormonal Treatment in Youths (<18) — finds that GnRHa treatment should be considered experimental due to lack of long-term data. Karolinska Institutet News

• Karolinska Hospital Policy Statement (April 2021) — stops prescribing puberty blockers and cross-sex hormones to minors under 16 except in research settings. Feminist Legal Clinic